Related Experiment Video
Updated: Nov 30, 2025

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Blood Glucose Control Strategy for Type 2 Diabetes Patients With COVID-19
Hiroyuki Futatsugi1, Masato Iwabu1, Miki Okada-Iwabu1,2
1Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Insights
Managing blood glucose levels is crucial for patients with type 2 diabetes mellitus, especially during the COVID-19 pandemic. Effective glycemic control may reduce severe COVID-19 outcomes.
Area of Science:
- Endocrinology
- Infectious Diseases
- Public Health
Background:
- The COVID-19 pandemic, caused by SARS-CoV-2, has affected millions globally.
- Type 2 diabetes mellitus is a significant risk factor for COVID-19 mortality.
- Limited evidence suggests blood glucose control may mitigate COVID-19 severity in diabetic patients.
Purpose of the Study:
- To review anti-diabetic agents in the context of COVID-19.
- To highlight the importance of glycemic control during the pandemic.
Main Methods:
- Literature review of anti-diabetic agents.
- Analysis of current evidence on COVID-19 and type 2 diabetes.
Main Results:
- The review discusses the profile of various anti-diabetic medications.
- Emphasis is placed on the critical role of blood glucose management.
Conclusions:
- Glycemic control is paramount for managing COVID-19 in patients with type 2 diabetes.
- Further research into anti-diabetic agents' role in COVID-19 is warranted.
Abstract:
Since December 2019, coronavirus disease 2019 (COVID-19) caused by a novel coronavirus has spread all over the world affecting tens of millions of people. Another pandemic affecting the modern world, type 2 diabetes mellitus is among the major risk factors for mortality from COVID-19. Current evidence, while limited, suggests that proper blood glucose control may help prevent exacerbation of COVID-19 even in patients with type 2 diabetes mellitus. Under current circumstances where the magic bullet for the disease remains unavailable, it appears that the role of blood glucose control cannot be stressed too much. In this review the profile of each anti-diabetic agent is discussed in relation to COVID-19.
More Related Videos
06:46A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
07:35Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique
Published on: January 26, 2024
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Hypoglycemia and Glucagon
Diabetes: Symptoms, Diagnosis, and Complications